ArticleThe Journal of biological chemistry

Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.

Kang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.